BIOMAT Database Logo BIOMAT Database Logo

Treatment of renal transplant-associated cytomegalovirus infection with ganciclovir. 1990

M L Nicholson, and P S Veitch, and P K Donnelly, and A J Flower, and P R Bell
Transplant Unit, Leicester, UK.

UI MeSH Term Description Entries
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D008297 Male Males
D011239 Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF
D003524 Cyclosporins A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. Cyclosporines
D003586 Cytomegalovirus Infections Infection with CYTOMEGALOVIRUS, characterized by enlarged cells bearing intranuclear inclusions. Infection may be in almost any organ, but the salivary glands are the most common site in children, as are the lungs in adults. CMV Inclusion,CMV Inclusions,Congenital CMV Infection,Congenital Cytomegalovirus Infection,Cytomegalic Inclusion Disease,Cytomegalovirus Colitis,Cytomegalovirus Inclusion,Cytomegalovirus Inclusion Disease,Cytomegalovirus Inclusions,Inclusion Disease,Perinatal CMV Infection,Perinatal Cytomegalovirus Infection,Renal Tubular Cytomegalovirus Inclusion,Renal Tubular Cytomegalovirus Inclusions,Salivary Gland Virus Disease,Severe Cytomegalovirus Infection,Severe Cytomegalovirus Infections,Infections, Cytomegalovirus,CMV Infection, Congenital,CMV Infection, Perinatal,Colitis, Cytomegalovirus,Congenital CMV Infections,Congenital Cytomegalovirus Infections,Cytomegalic Inclusion Diseases,Cytomegalovirus Colitides,Cytomegalovirus Inclusion Diseases,Cytomegalovirus Infection,Cytomegalovirus Infection, Congenital,Cytomegalovirus Infection, Perinatal,Cytomegalovirus Infection, Severe,Cytomegalovirus Infections, Severe,Disease, Cytomegalic Inclusion,Disease, Cytomegalovirus Inclusion,Diseases, Cytomegalovirus Inclusion,Inclusion Disease, Cytomegalic,Inclusion Disease, Cytomegalovirus,Inclusion Diseases,Inclusion Diseases, Cytomegalovirus,Inclusion, CMV,Inclusion, Cytomegalovirus,Infection, Congenital CMV,Infection, Congenital Cytomegalovirus,Infection, Cytomegalovirus,Infection, Perinatal CMV,Infection, Perinatal Cytomegalovirus,Infection, Severe Cytomegalovirus,Perinatal CMV Infections,Perinatal Cytomegalovirus Infections
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D001379 Azathioprine An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed) Azathioprine Sodium,Azathioprine Sodium Salt,Azathioprine Sulfate,Azothioprine,Immuran,Imuran,Imurel,Sodium, Azathioprine

Related Publications

M L Nicholson, and P S Veitch, and P K Donnelly, and A J Flower, and P R Bell
Prophylactic treatment of cytomegalovirus primary infection with ganciclovir in renal transplant recipients.
August 1995, Transplantation proceedings,
M L Nicholson, and P S Veitch, and P K Donnelly, and A J Flower, and P R Bell
Ganciclovir for treatment of renal transplant-associated primary cytomegalovirus pneumonia.
January 1988, The Journal of infectious diseases,
M L Nicholson, and P S Veitch, and P K Donnelly, and A J Flower, and P R Bell
Ganciclovir for cytomegalovirus infection in renal transplant recipients.
January 1989, Lancet (London, England),
M L Nicholson, and P S Veitch, and P K Donnelly, and A J Flower, and P R Bell
Transplant renal artery stenosis associated with acute cytomegalovirus infection: resolution following ganciclovir administration.
January 2009, Renal failure,
M L Nicholson, and P S Veitch, and P K Donnelly, and A J Flower, and P R Bell
Efficacy of early treatment of cytomegalovirus infection by ganciclovir in renal transplant recipients.
August 1990, Transplantation proceedings,
M L Nicholson, and P S Veitch, and P K Donnelly, and A J Flower, and P R Bell
Ganciclovir therapy of symptomatic cytomegalovirus infection in renal transplant recipients.
January 1989, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
M L Nicholson, and P S Veitch, and P K Donnelly, and A J Flower, and P R Bell
Cytomegalovirus infection resistant to ganciclovir in a renal transplant patient.
May 2003, Transplantation proceedings,
M L Nicholson, and P S Veitch, and P K Donnelly, and A J Flower, and P R Bell
Ganciclovir treatment for cytomegalovirus infections in renal transplant recipients.
October 1992, Transplantation proceedings,
M L Nicholson, and P S Veitch, and P K Donnelly, and A J Flower, and P R Bell
Ganciclovir pharmacokinetics and cytokine dynamics in renal transplant recipients with cytomegalovirus infection.
October 2001, Clinical transplantation,
M L Nicholson, and P S Veitch, and P K Donnelly, and A J Flower, and P R Bell
Effect of prophylactic ganciclovir on cytomegalovirus infection in renal transplant recipients.
January 1993, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
Copied contents to your clipboard!